losartan has been researched along with phosphatidylcholines in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choy, PC; Hatch, GM; Kroeger, EA; Lee, D; Man, RY | 2 |
| Alvarez, S; Carrizo, L; Manucha, W; Oliveros, L; Valles, P | 1 |
| Hodzic, A; Mavromoustakos, T; Pabst, G; Rappolt, M; Zoumpoulakis, P | 1 |
4 other study(ies) available for losartan and phosphatidylcholines
| Article | Year |
|---|---|
On the mechanism of the losartan-mediated inhibition of phosphatidylcholine biosynthesis in H9c2 cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cell Line; Cell Membrane; Choline; Cytosol; Imidazoles; Immunoblotting; Kinetics; Losartan; Phosphatidylcholines; Pyridines; Tetrazoles; Tritium | 1997 |
Losartan-mediated regulation of phospholipid biosynthesis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Line; Choline; Dose-Response Relationship, Drug; Losartan; Myocardium; Phosphatidylcholines; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 1997 |
Effect of losartan pretreatment on kidney lipid content after unilateral obstruction in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cholesterol; Fatty Acids; Female; Gene Expression Regulation; Kidney Cortex; Lipid Metabolism; Lipids; Losartan; Phosphatidylcholines; Phosphatidylethanolamines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Sphingomyelins; Ureteral Obstruction | 2005 |
Losartan's affinity to fluid bilayers modulates lipid-cholesterol interactions.
Topics: Cholesterol; Dimyristoylphosphatidylcholine; Lipid Bilayers; Losartan; Membrane Microdomains; Phosphatidylcholines | 2012 |